These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 24887036)
1. High density lipoprotein from patients with valvular heart disease uncouples endothelial nitric oxide synthase. Chang FJ; Yuan HY; Hu XX; Ou ZJ; Fu L; Lin ZB; Wang ZP; Wang SM; Zhou L; Xu YQ; Wang CP; Xu Z; Zhang X; Zhang CX; Ou JS J Mol Cell Cardiol; 2014 Sep; 74():209-19. PubMed ID: 24887036 [TBL] [Abstract][Full Text] [Related]
2. Circulating microparticles from patients with valvular heart disease and cardiac surgery inhibit endothelium-dependent vasodilation. Fu L; Hu XX; Lin ZB; Chang FJ; Ou ZJ; Wang ZP; Ou JS J Thorac Cardiovasc Surg; 2015 Sep; 150(3):666-72. PubMed ID: 26145768 [TBL] [Abstract][Full Text] [Related]
3. The oxidized phospholipid POVPC impairs endothelial function and vasodilation via uncoupling endothelial nitric oxide synthase. Yan FX; Li HM; Li SX; He SH; Dai WP; Li Y; Wang TT; Shi MM; Yuan HX; Xu Z; Zhou JG; Ning DS; Mo ZW; Ou ZJ; Ou JS J Mol Cell Cardiol; 2017 Nov; 112():40-48. PubMed ID: 28870504 [TBL] [Abstract][Full Text] [Related]
4. Microparticles from Patients with the Acute Coronary Syndrome Impair Vasodilatation by Inhibiting the Akt/eNOS-Hsp90 Signaling Pathway. Han WQ; Chang FJ; Wang QR; Pan JQ Cardiology; 2015; 132(4):252-60. PubMed ID: 26329646 [TBL] [Abstract][Full Text] [Related]
5. Endothelial microparticles increase in mitral valve disease and impair mitral valve endothelial function. Ci HB; Ou ZJ; Chang FJ; Liu DH; He GW; Xu Z; Yuan HY; Wang ZP; Zhang X; Ou JS Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E695-702. PubMed ID: 23384770 [TBL] [Abstract][Full Text] [Related]
6. Geranylgeranylacetone, heat shock protein 90/AMP-activated protein kinase/endothelial nitric oxide synthase/nitric oxide pathway, and endothelial function in humans. Fujimura N; Jitsuiki D; Maruhashi T; Mikami S; Iwamoto Y; Kajikawa M; Chayama K; Kihara Y; Noma K; Goto C; Higashi Y Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):153-60. PubMed ID: 21998134 [TBL] [Abstract][Full Text] [Related]
7. Amyloid β peptide-induced inhibition of endothelial nitric oxide production involves oxidative stress-mediated constitutive eNOS/HSP90 interaction and disruption of agonist-mediated Akt activation. Lamoke F; Mazzone V; Persichini T; Maraschi A; Harris MB; Venema RC; Colasanti M; Gliozzi M; Muscoli C; Bartoli M; Mollace V J Neuroinflammation; 2015 May; 12():84. PubMed ID: 25935150 [TBL] [Abstract][Full Text] [Related]
8. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Sorrentino SA; Besler C; Rohrer L; Meyer M; Heinrich K; Bahlmann FH; Mueller M; Horváth T; Doerries C; Heinemann M; Flemmer S; Markowski A; Manes C; Bahr MJ; Haller H; von Eckardstein A; Drexler H; Landmesser U Circulation; 2010 Jan; 121(1):110-22. PubMed ID: 20026785 [TBL] [Abstract][Full Text] [Related]
14. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Xi W; Satoh H; Kase H; Suzuki K; Hattori Y Biochem Biophys Res Commun; 2005 Jun; 332(1):200-5. PubMed ID: 15896318 [TBL] [Abstract][Full Text] [Related]
15. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. Nofer JR; van der Giet M; Tölle M; Wolinska I; von Wnuck Lipinski K; Baba HA; Tietge UJ; Gödecke A; Ishii I; Kleuser B; Schäfers M; Fobker M; Zidek W; Assmann G; Chun J; Levkau B J Clin Invest; 2004 Feb; 113(4):569-81. PubMed ID: 14966566 [TBL] [Abstract][Full Text] [Related]
16. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. Li R; Wang WQ; Zhang H; Yang X; Fan Q; Christopher TA; Lopez BL; Tao L; Goldstein BJ; Gao F; Ma XL Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1703-8. PubMed ID: 17895290 [TBL] [Abstract][Full Text] [Related]
17. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. Gong M; Wilson M; Kelly T; Su W; Dressman J; Kincer J; Matveev SV; Guo L; Guerin T; Li XA; Zhu W; Uittenbogaard A; Smart EJ J Clin Invest; 2003 May; 111(10):1579-87. PubMed ID: 12750408 [TBL] [Abstract][Full Text] [Related]
18. Chronic hypoxia increases endothelial nitric oxide synthase generation of nitric oxide by increasing heat shock protein 90 association and serine phosphorylation. Shi Y; Baker JE; Zhang C; Tweddell JS; Su J; Pritchard KA Circ Res; 2002 Aug; 91(4):300-6. PubMed ID: 12193462 [TBL] [Abstract][Full Text] [Related]
19. L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells. Ou Z; Ou J; Ackerman AW; Oldham KT; Pritchard KA Circulation; 2003 Mar; 107(11):1520-4. PubMed ID: 12654610 [TBL] [Abstract][Full Text] [Related]
20. 25-Hydroxycholesterol impairs endothelial function and vasodilation by uncoupling and inhibiting endothelial nitric oxide synthase. Ou ZJ; Chen J; Dai WP; Liu X; Yang YK; Li Y; Lin ZB; Wang TT; Wu YY; Su DH; Cheng TP; Wang ZP; Tao J; Ou JS Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E781-E790. PubMed ID: 27600825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]